Research Output per year
Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remissionReddy, M. S., Hofmann, S., Shen, Y. M., Nagalla, S., Rambally, S., Usmani, A. & Sarode, R., 2020, (Accepted/In press) In : Transfusion and Apheresis Science. 102885.
Research output: Contribution to journal › Article